Cargando…

The hospital anxiety and depression scale, in patients with multiple sclerosis

PURPOSE: Multiple sclerosis (MS) is a long-lasting disabling disease with psychological implications. Hospital Anxiety and Depression Scale (HADS) is a questionnaire developed to screen anxiety and depression among patients in hospital settings. The objective of this report was to study the metric p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pais-Ribeiro, José Luís, Martins da Silva, Ana, Vilhena, Estela, Moreira, Inês, Santos, Ernestina, Mendonça, Denisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257361/ https://www.ncbi.nlm.nih.gov/pubmed/30538477 http://dx.doi.org/10.2147/NDT.S184260

Ejemplares similares

Predictors of Quality of Life in Portuguese Obese Patients: A Structural Equation Modeling Application
por: Vilhena, Estela, et al.
Publicado: (2014)

Psychosocial factors as predictors of quality of life in chronic portuguese patients
por: Vilhena, Estela, et al.
Publicado: (2014)

Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
por: Tauil, C.B., et al.
Publicado: (2021)

Anxiety, emotional processing and depression in people with multiple sclerosis
por: Gay, Marie-Claire, et al.
Publicado: (2017)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

In Systemic Sclerosis, Anxiety and Depression Assessed by Hospital Anxiety Depression Scale Are Independently Associated with Disability and Psychological Factors
por: Del Rosso, Angela, et al.
Publicado: (2013)

Fatigue, Depression, and Anxiety Among Ambulating Multiple Sclerosis Patients
por: AlSaeed, Safanah, et al.
Publicado: (2022)

Psychometric Properties of the HADS Measure of Anxiety and Depression Among Multiple Sclerosis Patients in Croatia
por: Jerković, Ana, et al.
Publicado: (2021)

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines
por: Tauil, Carlos B., et al.
Publicado: (2020)

Work difficulties in people with multiple sclerosis: The role of anxiety, depression and coping
por: van Egmond, EEA, et al.
Publicado: (2022)

Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression
por: SEVIM, Serhan, et al.
Publicado: (2022)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study
por: Alsaadi, Taoufik, et al.
Publicado: (2015)

A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register
por: Jones, Kerina H., et al.
Publicado: (2012)

The Hospital Anxiety And Depression Scale
por: Snaith, R Philip
Publicado: (2003)

Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis
por: Kolahkaj, Bentolhoda, et al.
Publicado: (2015)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

The Effect of Group Cognitive Behavioral Therapy on Stress, Anxiety, and Depression of Women with Multiple Sclerosis
por: Pahlavanzadeh, Saeid, et al.
Publicado: (2017)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
por: Eid, Karine, et al.
Publicado: (2021)

Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system
por: Ortí, Jose Enrique de la Rubia, et al.
Publicado: (2023)

Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung’s Self-rating Anxiety Scale/Depression Scale
por: Cheng, Lu, et al.
Publicado: (2023)

Short version of the Depression Anxiety Stress Scale-21: is it valid for Brazilian adolescents?
por: da Silva, Hítalo Andrade, et al.
Publicado: (2016)

The factor structure of the Center for Epidemiological Study - Depression Scale in people with multiple sclerosis
por: Kneebone, Ian I., et al.
Publicado: (2020)

Symptoms of Anxiety and Depression in Young Athletes Using the Hospital Anxiety and Depression Scale
por: Weber, Stephanie, et al.
Publicado: (2018)

Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis
por: Michalski, Dominik, et al.
Publicado: (2010)

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
por: McKay, Kyla A., et al.
Publicado: (2015)

Prevalence of Anxiety and Depression in Patients With Multiple Sclerosis in Saudi Arabia: A Cross-Sectional Study
por: Aljishi, Rahaif H, et al.
Publicado: (2021)

Surviving a global pandemic: The experience of depression, anxiety, and loneliness among individuals with multiple sclerosis
por: Strober, L., et al.
Publicado: (2022)

Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia
por: Alharbi, Norah A., et al.
Publicado: (2022)

Effects of N‐acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis
por: Khalatbari Mohseni, Golsa, et al.
Publicado: (2023)

Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)
por: Covic, Tanya, et al.
Publicado: (2012)

The Validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s Disease
por: Mondolo, Federica, et al.
Publicado: (2006)

Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman
por: Al-Asmi, Abdullah, et al.
Publicado: (2015)

Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates
por: Alsaadi, Taoufik, et al.
Publicado: (2017)

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study
por: Karimi, Saba, et al.
Publicado: (2020)

The Levels of Depression, Anxiety, Acceptance of Illness, and Medication Adherence in Patients with Multiple Sclerosis - Descriptive and Correlational Study
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2021)

The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study
por: Bahathig, Ali, et al.
Publicado: (2020)

Psychosocial Impact of Multiple Sclerosis on Couples: Relationship Between Anxiety, Depression, and Stress Communication of Both Partners
por: Busch, Ada-Katrin, et al.
Publicado: (2022)

Proinflammatory Cytokines Correlate with Depression and Anxiety in Colorectal Cancer Patients
por: Oliveira Miranda, Diego, et al.
Publicado: (2014)

People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR(+) Tregs
por: Canto-Gomes, João, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cj5os8a68ttsnq9jcualg28e5n